Access challenges to cell and gene therapy are well documented. Precision’s Christina Poschen and David Carr discuss how some innovative manufacturers are moving away from the role of being purely a researcher and manufacturer and toward involvement at the point of diagnosis through manufacturing and delivery to patient access support in order to address those challenges head on.
Pharmaceutical manufacturers and payers have been involved in a back and forth dance regarding patient cost share practices – each action is met with a reaction. Precision’s Jeremy Schafer looks at the complex battle between pharmaceutical manufacturers and payers for balance between medication access and budget management.
Who typically has responsibility for Identity and Access Management within health plan organizations, and how does this role impact or protect their healthcare analytics objectives? Precision’s Dominic Galante contributes to the Thought Leaders Corner in this month’s Care Analytics News.
With the discipline of precision medicine as the foundation, Precision Medicine Group has Precision for Medicine’s next-gen clinical development and Precision Value & Health’s industry leading commercialization working together to accelerate the delivery of life science innovations. Visit the new Precision Medicine Group website, and see how we’re moving science closer to health.
Join Precision and Akara Group on Thursday, 8/6, 2020 | 12:00 PM EDT – 1:00 PM EDT for a special live, online discussion of best practices for pre-launch commercialization activities. Featuring Precision’s Brett DiNatale, learn about the latest advances in data, analytics, and technology, and understand how these latest advances can be used to improve decisions that impact GTN.
We’re excited to announce that PRECISIONvalue has been shortlisted for a 2020 MM&M award along with Takeda Oncology in the Use of Market Access Marketing category! And congratulations to our colleagues at PRECISIONeffect for their finalist nomination in the TV Advertising Campaign category.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
